A box of Mylan NV’s EpiPen 2-Pak allergy shots sit on display for a photograph at a pharmacy in Princeton, Ill., on Aug. 26. (Daniel Acker/Bloomberg)

Regarding Mark S. Weinberg’s Aug. 28 letter, “Combat drug prices with legislation”:

There already is a cheaper alternative to the EpiPen. The Food and Drug Administration approved it in 1939; it is called Adrenaclick. The indications for use of the EpiPen and Adrenaclick are the same: life-threatening allergic reaction called anaphylaxis.

I am allergic to certain insect stings, and my physician prescribes a generic epinephrine auto-injector, distributed by Lineage Therapeutics. After insurance, I pay $10 for a two-pack of injectors. According to Consumer Reports, “EpiPen isn’t the only epinephrine injector on the market; the authorized generic of Adrenaclick (epinephrine auto-injector), is a cheaper option — we found it for $142 at Walmart and Sam’s Club using a coupon from GoodRx. . . . Both auto-injectors contain the same drug, epinephrine, available in the same dosages.”

If the FDA and news outlets would educate the public about this alternative, meaningful competition and market forces would quickly bring down the cost of the EpiPen.

David A. Drachsler, Alexandria